Frank Yocca - Chief Scientific Officer at BioXcel Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Stock Symbol
BTAI on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Frank Yocca - trading volume in the past year for BioXcel Therapeutics, Inc.

Holdings reported by Frank Yocca for BioXcel Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 13,474 $17.2 K $1.28 Jun 17, 2024 Direct
Restricted Stock Units 6,188 $7.81 K $1.26 Jun 15, 2024 Direct Common Stock

Transactions reported by Frank Yocca for BioXcel Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership